Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. - Wikidata - awgldk - TriplyDB

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

http://www.wikidata.org/entity/Q36617328

about

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?Cancer-Associated Myeloid Regulatory Cells Genetics and biology of pancreatic ductal adenocarcinoma GEMMs as preclinical models for testing pancreatic cancer therapies Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles Neutralizing tumor-promoting chronic inflammation: a magic bullet?The impact of the myeloid response to radiation therapy Immune cell promotion of metastasis Genetically engineered mouse models of pancreatic adenocarcinoma Macrophages: gatekeepers of tissue integrity CD40 immunotherapy for pancreatic cancer Inflammatory networks and immune surveillance of pancreatic carcinoma Host immune response to infection and cancer: unexpected commonalities The spleen in local and systemic regulation of immunity Exploiting inflammation for therapeutic gain in pancreatic cancer Targeting tumor-associated macrophages to combat pancreatic cancer Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected T cell exclusion, immune privilege, and the tumor microenvironment ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis Inflammation and skeletal metastasis Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.A mathematical model for pancreatic cancer growth and treatments 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer.SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.The complex landscape of pancreatic cancer metabolism Stromal reengineering to treat pancreas cancer Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.Chemotherapy and tumor microenvironment of pancreatic cancer.Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer Ipilimumab augments antitumor activity of bispecific antibody-armed T cells Pancreatic cancer, inflammation, and microbiome.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages

P2860

Q24627664-7785D86E-9612-4965-B1C9-6E05237BEDE8 Q26747695-1CF50319-01AE-44C7-9E38-D2092CE866C3 Q26750382-B7A4E367-5A5C-4963-9262-4DFACA584786 Q26765438-CB4F3E32-A782-4B10-ABB4-CC1FBBF65BBB Q26781848-B708B99E-52E3-457A-84CA-433FCCC99819 Q26828959-63438F3A-9141-4553-ACD5-6D312945FD71 Q26830931-6217908B-794E-4E80-97FE-4D4CC2F408E6 Q26851643-29FC387E-2866-46BC-8366-97CA3794D7C8 Q26991724-015C7319-4193-4FAB-BB3B-D0BE0CA55015 Q27002973-199ECC64-1682-4325-A782-9525839765B7 Q27007092-7A6E0F6C-9DF7-430C-8ADE-D8F86EFC7797 Q27012550-E074E79D-AC0D-4092-9008-E6DE7A8D36C5 Q27013983-7DFD61C9-8F85-4524-A158-E9A6E7610CE1 Q27015410-D852C97E-1CAD-4E1D-A3E1-F260A09126E8 Q27025001-B4F0B9ED-A574-4533-98E8-909A279A78DD Q27027661-6130C45D-6B74-4E9B-AB5F-E92ED527EA1F Q28076103-7B3B3627-EA49-4AE7-AEAE-B66C1C8DFE0F Q28084627-650BFC6A-9C2D-463E-A6C4-6D9877F73492 Q28259872-0201BE51-E8EB-4175-83CD-900188AE179A Q28386923-B1719DBC-BE3D-47BA-9549-28A65AB923D3 Q28396089-CD57BAF2-BBA8-483B-8AE8-65981038A66B Q28504893-DEF6FA4D-A67C-4021-83C5-68E29AE08A7E Q30908891-61579B25-C7F1-4161-BCF2-B9A1B933AAC1 Q33560501-C45EADA5-4386-417E-8B25-61ACD9F93783 Q33571981-B2F4C4AC-01F2-4BFD-9E62-A4E64DCC893A Q33591328-2E62C333-6D3A-47AF-88B2-7C57377C799E Q33602583-F7D4835A-C9CE-4D18-9ABD-ED8480FE8381 Q33659934-91568D16-E7A8-46D9-BD22-E0D264026C27 Q33671350-B7D5D0E1-E835-4796-9AC8-9A09D889FE1D Q33779875-389C3D4C-8080-40DA-97F7-0A877D41DE59 Q33810570-3B5759CE-EBAD-405A-8F37-3ABC3F026F15 Q33827703-D4577EB5-FB30-49B9-8AEA-45D5E970F452 Q33827708-A63D322C-1BC3-4FA6-8BCB-7B5D0BB56A7F Q33838679-DB32162B-51C1-405D-BBC2-C482B54D3025 Q33851540-42FE0F0A-8CFD-4D0A-A0E6-6F5DFAD76B6F Q33876637-AEB4326C-6C53-4025-9F73-57F0A4B24DDD Q33888808-552559DC-D0D0-48A2-93AB-72F8E339F089 Q33929184-3E276751-661F-426B-B818-3AEA52CB4D78 Q33956107-DF0257B3-1042-480D-A503-B794C05381BC Q34044797-321E480E-BA9E-4D09-B22D-9FA1473D73A2

P2860

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

http://www.wikidata.org/entity/Q36617328

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@ast

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@en

type

label

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@ast

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@en

prefLabel

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@ast

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer.

@en

P1433

Q36617328-6986C86A-AE22-4D00-89F7-E6D786BE53E0

P1476

Q36617328-36989AF6-1B7A-461B-818E-E97CAEFF37E9

P2093

Q36617328-0194EFEC-B7A2-41DF-83E8-A69E855E34C0

Q36617328-0C182525-680F-462F-A63D-77C50A0BC667

Q36617328-49BF7B54-EE46-48E2-87A6-D1385DBF3047

Q36617328-87BB9B58-6087-4525-90F5-3C7B39023A56

Q36617328-A9995F56-989E-4AD5-B8CD-AB35D5D02356

Q36617328-E32694E0-2320-42A0-987E-89AD0DD276B9

P2860

Q36617328-08456FCB-D149-4DFD-9507-8F8FD4406FBA

Q36617328-153BAC0C-DD55-42FA-B675-678765845A0E

Q36617328-1BF00896-8927-493F-BEC9-0D922914C3B8

Q36617328-3255A1C8-2ED5-4802-A8EF-BA737BD8EF90

Q36617328-4C9F2C9E-78CD-4BA2-AE29-638B6C49FA6A

Q36617328-4E5D4945-07AB-4BC1-812F-11FE3072D647

Q36617328-5B6F3AF4-256D-4710-B20C-D5C958732180

Q36617328-5C1B82AD-3825-4E97-9DCC-FB6F1CCBE29E

Q36617328-61BCFA96-0174-4C83-A189-348E63E97E1F

Q36617328-66581DB4-1A9E-44FD-A764-FF1F8D84A64E

P304

Q36617328-849B4D54-F566-4A18-BAB6-E15DDE148E50

P31

Q36617328-A56058B3-5829-4849-9098-E640684A5AA8

P356

Q36617328-E8CD694E-CC43-4FE2-8952-3F38026A61D5

P433

Q36617328-F0CDE13E-6367-4290-9C1F-A72CED756C53

P478

Q36617328-82FB91D2-4497-4EE9-86ED-7E1900145875

P50

Q36617328-5556FF6D-FEFC-448F-B7E1-A10487B6FB98

P577

Q36617328-9BFFE4C6-41D8-4DB7-975A-1054D3757A97

P5875

Q36617328-B63054AA-DB17-43B1-AE0E-EF7F8FF48EDD

P698

Q36617328-0ECF1F67-EEB8-47B0-863D-2DE8AA78E9D5

P921

Q36617328-37404330-F97E-499C-B53C-2F1B85361140

P932

Q36617328-844738BD-809B-48D7-8058-A0BBFFE0417E

P356

J.CCR.2012.04.025

P1433

P1476

Tumor-derived granulocyte-macr ...... immunity in pancreatic cancer

@en

P2093

Andrew D Rhim

http://www.w3.org/2001/XMLSchema#string

Ben Z Stanger

http://www.w3.org/2001/XMLSchema#string

Carolyn E Clark

http://www.w3.org/2001/XMLSchema#string

Lauren J Bayne

http://www.w3.org/2001/XMLSchema#string

Nirag Jhala

http://www.w3.org/2001/XMLSchema#string

Robert H Vonderheide

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses

Myeloid-derived suppressor cells: linking inflammation and cancer

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Myeloid-derived suppressor cells as regulators of the immune system

Regulation of immune responses by L-arginine metabolism

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

EMT and dissemination precede pancreatic tumor formation

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.

P304

822-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2012.04.025

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Gregory L Beatty

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225373299

http://www.w3.org/2001/XMLSchema#string

P698

22698406

http://www.w3.org/2001/XMLSchema#string

P921

P932

3575028

http://www.w3.org/2001/XMLSchema#string